Minerva Neurosciences Inc

NASDAQ:NERV   3:59:53 PM EDT
9.55
+0.10 (+1.06%)
Products

Minerva Neurosciences Submits New Drug Application To FDA For Roluperidone For Treatment Of Negative Symptoms In Patients With Schizophrenia

Published: 08/22/2022 12:37 GMT
Minerva Neurosciences Inc (NERV) - Minerva Neurosciences Submits New Drug Application to FDA for Roluperidone for the Treatment of Negative Symptoms in Patients With Schizophrenia.